SynthesisProstate cancer and prostatic diseases2024

Cardiovascular risks of androgen receptor targeted agents in prostate cancer: a systematic review and meta-analysis.

Chloe Shu Hui Ong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.